Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-4-4
pubmed:abstractText
We have identified a t(8;9)(p21-23;p23-24) in seven male patients (mean age 50, range 32-74) with diverse hematologic malignancies and clinical outcomes: atypical chronic myeloid leukemia/chronic eosinophilic leukemia (n = 5), secondary acute myeloid leukemia (n = 1), and pre-B-cell acute lymphoblastic leukemia (n = 1). Initial fluorescence in situ hybridization studies of one patient indicated that the nonreceptor tyrosine kinase Janus-activated kinase 2 (JAK2) at 9p24 was disrupted. Rapid amplification of cDNA ends-PCR identified the 8p22 partner gene as human autoantigen pericentriolar material (PCM1), a gene encoding a large centrosomal protein with multiple coiled-coil domains. Reverse transcription-PCR and fluorescence in situ hybridization confirmed the fusion in this case and also identified PCM1-JAK2 in the six other t(8;9) patients. The breakpoints were variable in both genes, but in all cases the chimeric mRNA is predicted to encode a protein that retains several of the predicted coiled-coil domains from PCM1 and the entire tyrosine kinase domain of JAK2. Reciprocal JAK2-PCM1 mRNA was not detected in any patient. We conclude that human autoantigen pericentriolar material (PCM1)-JAK2 is a novel, recurrent fusion gene in hematologic malignancies. Patients with PCM1-JAK2 disease are attractive candidates for targeted signal transduction therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2662-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15805263-Acute Disease, pubmed-meshheading:15805263-Adult, pubmed-meshheading:15805263-Aged, pubmed-meshheading:15805263-Amino Acid Sequence, pubmed-meshheading:15805263-Autoantigens, pubmed-meshheading:15805263-Base Sequence, pubmed-meshheading:15805263-Cell Cycle Proteins, pubmed-meshheading:15805263-Chromosomes, Human, Pair 8, pubmed-meshheading:15805263-Chromosomes, Human, Pair 9, pubmed-meshheading:15805263-Humans, pubmed-meshheading:15805263-Janus Kinase 2, pubmed-meshheading:15805263-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:15805263-Leukemia, Myeloid, pubmed-meshheading:15805263-Male, pubmed-meshheading:15805263-Middle Aged, pubmed-meshheading:15805263-Molecular Sequence Data, pubmed-meshheading:15805263-Oncogene Proteins, Fusion, pubmed-meshheading:15805263-Protein-Tyrosine Kinases, pubmed-meshheading:15805263-Proto-Oncogene Proteins, pubmed-meshheading:15805263-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15805263-Translocation, Genetic
pubmed:year
2005
pubmed:articleTitle
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
pubmed:affiliation
III. Medizinische Universitätsklinik, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Mannheim, Germany. andreas.reiter@med3.ma.uni-heidelberg.de
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't